![](https://monteverdelaw.com/wp-content/uploads/case-logo/sesen-bio-inc.jpg)
Sesen Bio, Inc. (SESN), relating to its proposed merger with Carisma Therapeutics Inc. Under the terms of the agreement, SESN shareholders are expected to own approximately 41.7% of the combined company.
Sesen Bio, Inc. (SESN), relating to its proposed merger with Carisma Therapeutics Inc. Under the terms of the agreement, SESN shareholders are expected to own approximately 41.7% of the combined company.